High-resolution crystal structures of lysozyme in the presence of the potential drug VIV O(acetylacetonato)2 under two different experimental conditions have been solved. The crystallographic study reveals the loss of the ligands, the oxidation of VIV to VV and the subsequent formation of adducts of the protein with two different polyoxidovanadates: [V4 O12 ]4- , which interacts with lysozyme non-covalently, and the unprecedented [V20 O54 (NO3 )]n- , which is covalenty bound to the side chain of an aspartate residue of symmetry related molecules.
Keywords: Lysozyme; Polyhedra; Polyoxidovanadates; Protein Interaction; Vanadium; Vanadium-Based Drugs.
© 2023 The Authors. Angewandte Chemie International Edition published by Wiley-VCH GmbH.